In the past 15 years, important cornerstones for the understanding of chronic prurigo were laid (e.g., first disease definition, first guideline, first clinical trials, first approved systemic therapy).

The growing knowledge of the pathophysiology of chronic prurigo including new therapeutic targets enables the development of new, promising drugs that are urgently needed, as the burden of disease is high for affected patients.